NCT05690230 - Improving Patient Experience: BMBA | Crick

Overview

This study seeks to determine if patients undergoing a bone marrow biopsy/aspiration (BMBA) procedure who receive distraction techniques have lower levels of distress and pain, and higher post-procedure satisfaction, compared to those receiving standard-of-care. Intervention 1 is guided meditation in a virtual reality (VR) headset. Intervention 2 is comprised of environmental changes to the room (via nature-themed decals) and music.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

60

Conditions

Bone Marrow Cancer Leukemia Lymphoma Multiple Myeloma Hematologic Cancer

Interventions

Virtual realityOTHER

Patients will be provided with a wireless virtual reality headset that contains a guided meditation application. The application allows users to select their preferred music, visual setting, and a topic for meditation.

Environmental changesOTHER

A nature themed wall mural decal will be installed in the procedure room and the in-room computer will play music from Pandora. A selection of suggested stations will be provided, with the option for outside selections.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Provide signed and dated informed consent form * Willing to comply with all study procedures * Over 18 years of age * Prior history of at least 1 (one) BMBA at Jefferson outpatient oncology office within the past 2 (two) years * Visiting the Jefferson outpatient oncology office for a BMBA procedure during the study duration Exclusion Criteria: * Inability to read questions in English * Inability to answer questions autonomously * History of vertigo * Legal blindness in both eyes * Severe or profound hearing loss, or deafness

Locations (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Distress score

The primary outcome will be reported on a scale of 0-10, based on the National Comprehensive Cancer Network (NCCN) Distress Thermometer, 0 signifying "no distress" and 10 signifying "extreme distress." This scale is standardly used with oncology patients to determine their distress levels-distress refers to "an unpleasant experience of a mental, physical, social, or spiritual nature. It can affect the way you think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment."

Time frame: Within 10 minutes pre-procedure

Distress score

The primary outcome will be reported on a scale of 0-10, based on the National Comprehensive Cancer Network (NCCN) Distress Thermometer, 0 signifying "no distress" and 10 signifying "extreme distress." This scale is standardly used with oncology patients to determine their distress levels-distress refers to "an unpleasant experience of a mental, physical, social, or spiritual nature. It can affect the way you think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment."

Time frame: Within 10 minutes post-procedure

Secondary Outcomes

Pain intensity

To assess patient pain scores related to their BMBA procedure. This will be measured through the 0-10 Numeric Pain Intensity Scale, 0 signifying "no pain" and 10 signifying "the worst pain imaginable."

Time frame: Within 10 minutes pre-procedure

Pain intensity

To assess patient pain scores related to their BMBA procedure. This will be measured through the 0-10 Numeric Pain Intensity Scale, 0 signifying "no pain" and 10 signifying "the worst pain imaginable."

Time frame: Within 10 minutes post-procedure

Patient satisfaction

To assess patient satisfaction with their procedure. This will be assessed through a patient satisfaction survey including Likert-type questions.